NCT05709483View on ClinicalTrials.gov

Predictors of Aspirin Failure in Preeclampsia Prevention

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

April 13, 2023

Primary Completion Date

November 1, 2025

Study Completion Date

November 1, 2025

Conditions
Preeclampsia
Interventions
DRUG

Aspirin

Platelet assays including VerifyNow Aspirin assay, VerifyNow Base assay, platelet aggregometry, Thromboxana A2 levels- will be measured at baseline and 1 hour after administration of single-dose enteric-coated 81 mg aspirin

Trial Locations (1)

10065

RECRUITING

Rockefeller University, New York

All Listed Sponsors
lead

Rockefeller University

OTHER